Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation

被引:33
|
作者
Hallenborg, P. [1 ,2 ]
Feddersen, S. [2 ]
Francoz, S. [3 ]
Murano, I. [4 ]
Sundekilde, U. [2 ]
Petersen, R. K. [1 ]
Akimov, V. [2 ]
Olson, M. V. [5 ]
Lozano, G. [5 ]
Cinti, S. [4 ]
Gjertsen, B. T. [6 ]
Madsen, L. [1 ,7 ]
Marine, J-C [3 ]
Blagoev, B. [2 ]
Kristiansen, K. [1 ]
机构
[1] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark
[2] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark
[3] VIB KU Leuven, Lab Mol Canc Biol, B-3000 Louvain, Belgium
[4] Univ Politecn Marche, Dept Expt & Clin Med, I-60121 Ancona, Italy
[5] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA
[6] Univ Bergen, Inst Med, N-5021 Bergen, Norway
[7] Natl Inst Nutr & Seafood Res, N-5021 Bergen, Norway
来源
CELL DEATH AND DIFFERENTIATION | 2012年 / 19卷 / 08期
关键词
Mdm2; adipogenesis; CREB; Crtc2; C/EBP-BETA; TRANSCRIPTIONAL REGULATION; COACTIVATOR TORC2; TARGET GENES; PPAR-GAMMA; ADIPOGENESIS; BINDING; AMPLIFICATION; ACTIVATION; EXPRESSION;
D O I
10.1038/cdd.2012.15
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of the E3 ubiquitin ligase murine double minute 2 (Mdm2) in regulating the stability of the p53 tumor suppressor is well documented. By contrast, relatively little is known about p53-independent activities of Mdm2 and the role of Mdm2 in cellular differentiation. Here we report a novel role for Mdm2 in the initiation of adipocyte differentiation that is independent of its ability to regulate p53. We show that Mdm2 is required for cAMP-mediated induction of CCAAT/enhancer-binding protein delta (C/EBP delta) expression by facilitating recruitment of the cAMP regulatory element-binding protein (CREB) coactivator, CREB-regulated transcription coactivator (Crtc2)/TORC2, to the c/ebp delta promoter. Our findings reveal an unexpected role for Mdm2 in the regulation of CREB-dependent transactivation during the initiation of adipogenesis. As Mdm2 is able to promote adipogenesis in the myoblast cell line C2C12, it is conceivable that Mdm2 acts as a switch in cell fate determination. Cell Death and Differentiation (2012) 19, 1381-1389; doi:10.1038/cdd.2012.15; published online 2 March 2012
引用
收藏
页码:1381 / 1389
页数:9
相关论文
共 50 条
  • [41] Arachidonic acid-dependent gene regulation during preadipocyte differentiation controls adipocyte potential
    Nikolopoulou, Evanthia
    Papacleovoulou, Georgia
    Jean-Alphonse, Frederic
    Grimaldi, Giulia
    Parker, Malcolm G.
    Hanyaloglu, Aylin C.
    Christian, Mark
    JOURNAL OF LIPID RESEARCH, 2014, 55 (12) : 2479 - 2490
  • [42] E2F1-dependent oncogenic addiction of melanoma cells to MDM2
    Verhaegen, M.
    Checinska, A.
    Riblett, M. B.
    Wang, S.
    Soengas, M. S.
    ONCOGENE, 2012, 31 (07) : 828 - 841
  • [43] Therapeutic potential of splicing in RMS: SRSF2 binding modulation controls MDM2 alternative splicing
    Montes, Matias I.
    Comiskey, Daniel F.
    Khurshid, Safiya
    Chandler, Dawn S.
    CANCER RESEARCH, 2020, 80 (14) : 102 - 103
  • [44] Mdm2 plays a positive role as an effector of p53-dependent responses
    Giono, Luciana E.
    Manfredi, James J.
    CELL CYCLE, 2007, 6 (17) : 2143 - 2147
  • [45] Tissue-specific and age-dependent effects of global Mdm2 loss
    Zhang, Yun
    Xiong, Shunbin
    Li, Qin
    Hu, Sophia
    Tashakori, Mehrnoosh
    Van Pelt, Carolyn
    You, Mingjian James
    Pageon, Laura
    Lozano, Guillermina
    JOURNAL OF PATHOLOGY, 2014, 233 (04): : 380 - 391
  • [46] MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation
    Jin, YT
    Zeng, SX
    Lee, H
    Lu, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 20035 - 20043
  • [47] MDM2 displays differential activities dependent upon the activation status of NFκB
    Cheney, Misty D.
    McKenzie, Pamela P.
    Volk, Erin L.
    Fan, Liying
    Harris, Linda C.
    CANCER BIOLOGY & THERAPY, 2008, 7 (01) : 38 - 44
  • [48] Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression
    Meng, RD
    Shih, H
    Prabhu, NS
    George, DL
    El-Deiry, WS
    CLINICAL CANCER RESEARCH, 1998, 4 (01) : 251 - 259
  • [49] Mdm2 inhibition of p53 induces E2F1 transactivation via p21
    Mark Wunderlich
    Steven J Berberich
    Oncogene, 2002, 21 : 4414 - 4421
  • [50] Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification
    Lyle, Pamela L.
    Bridge, Julia A.
    Simpson, Jean F.
    Cates, Justin M.
    Sanders, Melinda E.
    HISTOPATHOLOGY, 2016, 68 (07) : 1040 - 1045